These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8867876)

  • 1. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing.
    Duka T; Redemann B; Voet B
    Psychopharmacology (Berl); 1995 Jun; 119(3):315-24. PubMed ID: 7675968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine.
    Curran HV; Pooviboonsuk P; Dalton JA; Lader MH
    Psychopharmacology (Berl); 1998 Jan; 135(1):27-36. PubMed ID: 9489931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93 426: antagonism of lormetazepam's psychotropic effects.
    Duka T; Goerke D; Dorow R; Höller L; Fichte K
    Psychopharmacology (Berl); 1988; 95(4):463-71. PubMed ID: 2905500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-carbolines as tools in memory research: human data with the beta-carboline ZK 93426.
    Duka T; Edelmann V; Schütt B; Dorow R
    Psychopharmacol Ser; 1988; 6():246-60. PubMed ID: 3064085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines.
    Sarter M; Bodewitz G; Stephens DN
    Psychopharmacology (Berl); 1988; 94(4):491-5. PubMed ID: 2836875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-induced electrocortical slowing.
    Riekkinen P; Riekkinen M; Sirviö J; Riekkinen P
    Psychopharmacology (Berl); 1993; 111(2):195-201. PubMed ID: 7870952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of benzodiazepine receptor ligands on the performance of an operant delayed matching to position task in rats: opposite effects of FG 7142 and lorazepam.
    Cole BJ; Hillmann M
    Psychopharmacology (Berl); 1994 Jul; 115(3):350-7. PubMed ID: 7871075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.
    McGaughy J; Sarter M
    Psychopharmacology (Berl); 1995 Feb; 117(3):340-57. PubMed ID: 7770610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ZK 93,426, a beta-carboline benzodiazepine receptor antagonist on night sleep pattern in healthy male volunteers.
    Duka T; Goerke D; Fichte K
    Psychopharmacology (Berl); 1995 Jan; 117(2):178-85. PubMed ID: 7753965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine attenuates scopolamine-induced memory impairment in humans.
    Riedel W; Hogervorst E; Leboux R; Verhey F; van Praag H; Jolles J
    Psychopharmacology (Berl); 1995 Nov; 122(2):158-68. PubMed ID: 8848531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
    Curran HV; Schifano F; Lader M
    Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine-induced amnesia in humans: lack of effects of the benzodiazepine receptor antagonist β-carboline ZK 93426.
    Duka T; Edelmann V; Schütt B; Dorow R; Fichte K
    J Psychopharmacol; 1992 Jan; 6(3):382-8. PubMed ID: 22291384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam.
    Hege SG; Ellinwood EH; Wilson WH; Helligers CA; Graham SM
    Psychopharmacology (Berl); 1997 May; 131(2):101-7. PubMed ID: 9201796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.
    Mintzer MZ; Griffiths RR
    Cogn Affect Behav Neurosci; 2007 Jun; 7(2):120-9. PubMed ID: 17672383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.
    Flicker C; Serby M; Ferris SH
    Psychopharmacology (Berl); 1990; 100(2):243-50. PubMed ID: 2305013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions.
    Rammsayer TH; Rodewald S; Groh D
    Brain Res Cogn Brain Res; 2000 Jan; 9(1):61-71. PubMed ID: 10666558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociative effects of scopolamine on working memory in healthy young volunteers.
    Rusted JM
    Psychopharmacology (Berl); 1988; 96(4):487-92. PubMed ID: 3149771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust.
    Kamboj SK; Curran HV
    Psychopharmacology (Berl); 2006 May; 185(4):529-35. PubMed ID: 16555061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.